Preferred Label : montelukast;

Obsolete resource : false;

MeSH note : a leukotriene D4 receptor antagonist; sodium salt is the active compound; structure in first source;

CISMeF synonym : MK 0476; singulair; cahill may roberts brand of montelukast sodium; merck brand of montelukast sodium; merck frosst brand of montelukast sodium; merck sharp & dohme brand of montelukast sodium;

MeSH synonym : 1-((((1R)-1-(3-((E)-2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)-cyclopropaneacetic acid;

MeSH hyponym : MK-0476; sodium 1-(((1-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropylacetate;

MeSH CAS label : cyclopropaneacetic acid, 1-((((1R)-1-(3-((E)-2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)-;

MeSH Related Number : montelukast sodium; 151767-02-1 (sodium); 158966-92-8 (montelukast); U1O3J18SFL;

Registry Number MeSH : 158966-92-8;

Related CAS MeSH : 151767-02-1 (montelukast sodium);

related registry number list (CISMeF) : 151767-02-1 (sodium);

Is substance : O;

UNII : MHM278SD3E;

InChIKey : UCHDWCPVSPXUMX-TZIWLTJVSA-N;

Details


Main resources

You can consult :


https://ansm.sante.fr/informations-de-securite/montelukast-singulair-et-generiques-risque-de-survenue-deffets-indesirables-neuropsychiatriques-renforcement-des-mises-en-garde
https://ansm.sante.fr/actualites/montelukast-singulair-et-generiques-indique-dans-le-traitement-de-lasthme-lansm-rappelle-les-risques-de-survenue-deffets-indesirables-neuropsychiatriques
2020
false
false
false
France
French
mental disorders
nervous system diseases
montelukast
pharmacovigilance note
montelukast
drug monitoring
anti-asthmatic agents
acetates
quinolines

---
http://www.has-sante.fr/portail/jcms/c_2579437/fr/singulair-montelukast-antileucotriene
http://www.has-sante.fr/portail/jcms/c_2579437/fr/
2015
true
France
French
montelukast sodium
child
adult
treatment outcome
infant
guidelines for drug use
drug therapy, combination
montelukast
administration, oral
anti-asthmatic agents
leukotriene antagonists
acetates
quinolines
insurance, health, reimbursement
montelukast
asthma
asthma, exercise-induced
evaluation of the transparency committee

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67632249
2012
France
summary of product characteristics
package leaflet
tablets
montelukast

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65896392
2012
France
summary of product characteristics
package leaflet
tablets
montelukast

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60906982
2012
France
summary of product characteristics
package leaflet
tablets
montelukast

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65800659
2012
France
summary of product characteristics
package leaflet
montelukast
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61858070
2012
France
summary of product characteristics
package leaflet
montelukast
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62592733
2012
France
summary of product characteristics
package leaflet
montelukast
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63468069
2012
France
summary of product characteristics
package leaflet
tablets
montelukast

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67435629
2012
France
summary of product characteristics
package leaflet
tablets
montelukast

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61635473
2012
France
summary of product characteristics
package leaflet
tablets
montelukast

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64561462
2012
France
summary of product characteristics
package leaflet
montelukast
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63842168
2012
France
summary of product characteristics
package leaflet
montelukast

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64723206
2012
France
summary of product characteristics
package leaflet
montelukast
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69354802
2012
France
summary of product characteristics
package leaflet
montelukast
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67040436
2012
France
summary of product characteristics
package leaflet
tablets
montelukast

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68283672
2012
France
summary of product characteristics
package leaflet
montelukast
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60990208
2012
France
summary of product characteristics
package leaflet
tablets
montelukast

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63122213
2012
France
summary of product characteristics
package leaflet
montelukast
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66337630
2012
France
summary of product characteristics
package leaflet
tablets
montelukast

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64431294
2012
France
summary of product characteristics
package leaflet
montelukast
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62202642
2012
France
summary of product characteristics
package leaflet
tablets
montelukast

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65726148
2012
France
summary of product characteristics
package leaflet
montelukast
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67943111
2012
France
summary of product characteristics
package leaflet
tablets
montelukast

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62456078
2012
France
summary of product characteristics
package leaflet
tablets
montelukast

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61290319
2012
France
summary of product characteristics
package leaflet
montelukast
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63282641
2012
France
summary of product characteristics
package leaflet
montelukast
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68501612
2012
France
summary of product characteristics
package leaflet
montelukast
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65626411
2012
France
summary of product characteristics
package leaflet
montelukast
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65291297
2012
France
summary of product characteristics
package leaflet
tablets
montelukast

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64758381
2012
France
summary of product characteristics
package leaflet
montelukast
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61689332
2012
France
summary of product characteristics
package leaflet
tablets
montelukast

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63821761
2012
France
summary of product characteristics
package leaflet
tablets
montelukast

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61596579
2012
France
summary of product characteristics
package leaflet
montelukast
tablets

---
http://www.lecrat.eu/?s=Montelukast
2011
France
French
pregnancy
anti-asthmatic agents
leukotriene antagonists
breast feeding
acetates
quinolines
montelukast
montelukast
acetates
quinolines
drug information

---
http://www.aboutkidshealth.ca/Fr/HealthAZ/Drugs/Pages/Montelukast.aspx
http://www.aboutkidshealth.ca/en/healthaz/drugs/pages/montelukast.aspx?k=mont%c3%a9lukast;+antagoniste+des+r%c3%a9cepteurs+des+leucotri%c3%a8nes;+asthme
2010
Canada
French
English
child
montelukast
montelukast
acetates
acetates
quinolines
quinolines
administration, oral
anti-asthmatic agents
anti-asthmatic agents
montelukast
acetates
quinolines
patient education handout
drug information

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-05/singulair_ct_6895.pdf
http://www.has-sante.fr/portail/jcms/c_883288/singulair
http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-11/singulair_4_mg_-_ct-6895.pdf
2009
Haute Autorité de santé
France
French
English
French pre-residency program examination
evaluation of the transparency committee
corticosteroid therapy
child
treatment outcome
montelukast
administration, oral
acetates
quinolines
anti-asthmatic agents
montelukast
insurance, health, reimbursement

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-11/singulair_4_mg_-_ct-6895.pdf
http://www.has-sante.fr/portail/jcms/c_883288/singulair
2009
false
false
Haute Autorité de santé
France
French
corticosteroid therapy
montelukast
child
acetates
anti-asthmatic agents
leukotriene antagonists
quinolines
montelukast
insurance, health, reimbursement
asthma
asthma, exercise-induced
treatment outcome
acetates
quinolines
guidelines for drug use
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-11/singulair_5_mg_-_10_mg_-_ct-7112.pdf
http://www.has-sante.fr/portail/jcms/c_883295/singulair
2009
France
French
corticosteroid therapy
montelukast
administration, oral
anti-asthmatic agents
leukotriene antagonists
acetates
quinolines
insurance, health, reimbursement
montelukast
asthma
asthma, exercise-induced
acetates
quinolines
evaluation of the transparency committee

---
https://www.minerva-ebp.be/fr/article/802
2005
false
false
minerva-ebm.be
Belgium
French
Fluticasone-Salmeterol Drug Combination
asthma
anti-asthmatic agents
leukotriene antagonists
quinolines
acetates
adult
bronchodilator agents
adrenergic beta-agonists
treatment outcome
asthma
montelukast
acetates
critical appraisal or critical reading
comparative study

---
Nous contacter.
20/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.